Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid for reducing blood loss and improving surgical field in endoscopic sinus surgery
IRCT201010265026N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in Hemorrhagic syndrome and rhinosinusitis, sponsored by Tehran University of Medical Sciences. Primary endpoints: Intraoperative blood loss and Quality of surgical field. Started Apr 2009; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Hemorrhagic syndromerhinosinusitis
Beyond the preview
Go deeper on IRCT201010265026N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201010265026N1.